Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Subcutaneous nemolizumab , in addition to topical agents for atopic dermatitis , resulted in a greater reduction in pruritus than placebo plus topical agents. The incidence of injection-site reactions was more significant with nemolizumab than with placebo.
…